Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna Lopes da Costa

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|May 2, 2022
CRISPR/Cas therapeutic strategies for autosomal dominant disordersSalvatore Marco Caruso, Peter Mj Quinn, Bruna Lopes da Costa, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 10, 2025
Generation of Retinal Organoids Using Human-Induced Pluripotent Stem CellsKeith Theodore, Joel Alan Imventarza, Saleha Tahir, et al.
Advances in Experimental Medicine and Biology|July 13, 2023
Generation of CRB1 RP Patient-Derived iPSCs and a CRISPR/Cas9-Mediated Homology-Directed Repair Strategy for the CRB1 c.2480G>T MutationBruna Lopes da Costa, Yao Li, Sarah R Levi, et al.
Advances in Experimental Medicine and Biology|February 10, 2025
Prime Editing Strategy to Install the Mfrp Retinal Degeneration 6 MutationBruna Lopes da Costa, Jorge Pincay, Scott E Brodie, et al.
Frontiers in Genome Editing|December 13, 2021
Prime Editing for Inherited Retinal DiseasesBruna Lopes da Costa, Sarah R Levi, Eric Eulau, et al.
Advances in Experimental Medicine and Biology|July 13, 2023
Analysis of CRB1 Pathogenic Variants Correctable with CRISPR Base and Prime EditingBruna Lopes da Costa, Laura A Jenny, Irene H Maumenee, et al.
Advances in Experimental Medicine and Biology|February 10, 2025
Megabase Deletion of the Human EYS Locus Using CRISPR/Cas9Bruna Lopes da Costa, Anders Steen Knudsen, C Henrique Alves, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|October 7, 2023
A novel pathogenic CRB1 variant presenting as Leber Congenital Amaurosis 8 and evaluation of gene editing feasibilityMohamed M Sylla, Masha Kolesinkova, Bruna Lopes da Costa, et al.
Biomedicines|February 25, 2023
Clinical and Therapeutic Evaluation of the Ten Most Prevalent <i>CRB1</i> MutationsBruna Lopes da Costa, Masha Kolesnikova, Sarah R Levi, et al.
Advances in Experimental Medicine and Biology|July 13, 2023
Prime Editing Strategy to Install the PRPH2 c.828+1G>A MutationSalvatore Marco Caruso, Yi-Ting Tsai, Bruna Lopes da Costa, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|May 2, 2022
CRISPR/Cas therapeutic strategies for autosomal dominant disordersSalvatore Marco Caruso, Peter Mj Quinn, Bruna Lopes da Costa, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 10, 2025
Generation of Retinal Organoids Using Human-Induced Pluripotent Stem CellsKeith Theodore, Joel Alan Imventarza, Saleha Tahir, et al.
Advances in Experimental Medicine and Biology|July 13, 2023
Generation of CRB1 RP Patient-Derived iPSCs and a CRISPR/Cas9-Mediated Homology-Directed Repair Strategy for the CRB1 c.2480G>T MutationBruna Lopes da Costa, Yao Li, Sarah R Levi, et al.
Advances in Experimental Medicine and Biology|February 10, 2025
Prime Editing Strategy to Install the Mfrp Retinal Degeneration 6 MutationBruna Lopes da Costa, Jorge Pincay, Scott E Brodie, et al.
Frontiers in Genome Editing|December 13, 2021
Prime Editing for Inherited Retinal DiseasesBruna Lopes da Costa, Sarah R Levi, Eric Eulau, et al.
Advances in Experimental Medicine and Biology|July 13, 2023
Analysis of CRB1 Pathogenic Variants Correctable with CRISPR Base and Prime EditingBruna Lopes da Costa, Laura A Jenny, Irene H Maumenee, et al.
Advances in Experimental Medicine and Biology|February 10, 2025
Megabase Deletion of the Human EYS Locus Using CRISPR/Cas9Bruna Lopes da Costa, Anders Steen Knudsen, C Henrique Alves, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|October 7, 2023
A novel pathogenic CRB1 variant presenting as Leber Congenital Amaurosis 8 and evaluation of gene editing feasibilityMohamed M Sylla, Masha Kolesinkova, Bruna Lopes da Costa, et al.
Biomedicines|February 25, 2023
Clinical and Therapeutic Evaluation of the Ten Most Prevalent <i>CRB1</i> MutationsBruna Lopes da Costa, Masha Kolesnikova, Sarah R Levi, et al.
Advances in Experimental Medicine and Biology|July 13, 2023
Prime Editing Strategy to Install the PRPH2 c.828+1G>A MutationSalvatore Marco Caruso, Yi-Ting Tsai, Bruna Lopes da Costa, et al.
Pageof 3